We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Vortioxetine hydrobromide

Australian Public Assessment Report

AusPAR

AusPAR: Vortioxetine hydrobromide [PDF, 1.47 MB]

AusPAR: Vortioxetine hydrobromide [Word, 3.49 MB]

Attachment: Product Information: Vortioxetine hydrobromide [PDF, 290 KB]

Attachment: Product Information: Vortioxetine hydrobromide [Word, 106.09 KB]

Attachment: Extract from Clinical Evaluation Report: Vortioxetine hydrobromide [PDF, 2.03 MB]

Attachment: Extract from Clinical Evaluation Report: Vortioxetine hydrobromide [Word, 4.83 MB]

Device/Product Name

Brintellix

Active ingredients

Vortioxetine hydrobromide

AusPAR Date

8 July 2014

Published

4 August 2014

Submission Number

PM-2012-03463-1-1

Submission Type

New chemical entity

Decision

Approved